STEM vs. NVX, ULBI, GWH, ELVA, FLUX, SES, DOMO, ATNI, TGAN, and MVIS
Should you be buying Stem stock or one of its competitors? The main competitors of Stem include NOVONIX (NVX), Ultralife (ULBI), ESS Tech (GWH), Electrovaya (ELVA), Flux Power (FLUX), SES AI (SES), Domo (DOMO), ATN International (ATNI), Transphorm (TGAN), and MicroVision (MVIS). These companies are all part of the "computer and technology" sector.
Stem (NYSE:STEM) and NOVONIX (NASDAQ:NVX) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, media sentiment, risk, valuation, earnings and dividends.
Stem has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, NOVONIX has a beta of 3.16, suggesting that its stock price is 216% more volatile than the S&P 500.
Stem received 27 more outperform votes than NOVONIX when rated by MarketBeat users.
NOVONIX has lower revenue, but higher earnings than Stem.
61.6% of Stem shares are owned by institutional investors. Comparatively, 0.1% of NOVONIX shares are owned by institutional investors. 10.2% of Stem shares are owned by company insiders. Comparatively, 23.7% of NOVONIX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, Stem had 13 more articles in the media than NOVONIX. MarketBeat recorded 15 mentions for Stem and 2 mentions for NOVONIX. NOVONIX's average media sentiment score of 0.00 beat Stem's score of -0.59 indicating that NOVONIX is being referred to more favorably in the news media.
NOVONIX has a net margin of 0.00% compared to Stem's net margin of -40.03%. NOVONIX's return on equity of 0.00% beat Stem's return on equity.
Stem currently has a consensus price target of $5.23, indicating a potential upside of 284.90%. Given Stem's higher probable upside, research analysts clearly believe Stem is more favorable than NOVONIX.
Summary
NOVONIX beats Stem on 8 of the 14 factors compared between the two stocks.
Get Stem News Delivered to You Automatically
Sign up to receive the latest news and ratings for STEM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
